Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV), which can easily evolve into chronic hepatitis, liver cirrhosis and liver cancer. It is understood that the rate of hepatitis C infection in China is as high as 3.2%, and there are about 40 million hepatitis C patients nationwide, of whom about 40% to 50% will develop chronic hepatitis C, and about 25% will eventually develop cirrhosis, which seriously affects the liver health of the public. Hepatitis C is known as the “silent killer” and early symptoms are often mild, with patients experiencing poor appetite, fatigue, nausea, stomach pain, yellow urine and yellow sclera. Many patients often think it is a stomach flu, cold or fire and do not pay attention to it and actively treat it, so hepatitis C often progresses and worsens unknowingly. Hepatitis C is mainly transmitted through blood transmission, mother-to-child transmission, sexual transmission, and injection drug use. High-risk factors for hepatitis C infection include: a spouse or mother with hepatitis C, a history of blood or blood product transfusions, having received an organ transplant, sharing syringes for drug use, sharing razors, toothbrushes, razors, tattoos, etc. We recommend that people with high-risk factors come to our hospital for a hepatitis C antibody test; if they are positive for hepatitis C, they need to be tested for the hepatitis C RNA virus. Hepatitis C is a serious risk to the patient’s liver health and there is a risk of transmission to family members. For this reason, we recommend that patients who are positive for the hepatitis C RNA virus be treated aggressively with antiviral therapy. There are already effective medications available for the treatment of hepatitis C. Interferon injections and ribavirin are two effective medications for hepatitis C. With aggressive anti-Hepatitis C virus treatment, about 85 to 90% of patients with Hepatitis C can achieve Hepatitis C virus conversion. The course of antiviral treatment for hepatitis C is 1 year and costs about $60,000.